INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 219
RESEARCH DOSSIER / NOT AN ENDORSEMENT

SkinnyRx

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

GLP-1 weight-loss programs with $149/$199 price points visible on homepage cards.

Audienceread

Read: weight-loss telehealth consumer.

Pricing & termssnapshot

Sema/tirz injections $99 first month; sema tablets $149 and tirz tablets $199 first month. Ongoing GLP price unverified. Sermorelin from $199/month.

Clinical relationshipspartial

Lean Rx, Inc. operates platform, not medical practice/pharmacy. Independent US-licensed providers; treating legal entity not named. Sajad Zalzala, MD is advertised Medical Director.

Pharmacy & fulfillmentpartial

Independent US state-licensed pharmacies advertised; specific dispensing partners not established in reviewed current terms/FAQ.

Advertising snapshotsnapshot

US last-30-days domain lookup, 15 Oct 2026: about 500 ads. Advertiser labels: LeanRx Inc.. Counter/grid inconsistencies and historical retained cards are not active-ad or spend proof. US active exact-keyword lookup, 15 Oct 2026: about 62 keyword results; SkinnyRx and other GLP/beauty pages, not brand-only count. ID2166527170568450 started21Sep, ID2177994850263958 started15Oct.

Founding yearpartial

BBB lists business started 19 January 2019 for LeanRX/ SkinnyRX; not assumed date of current brand launch.

Foundersnot_found

Not established from reviewed free public sources as of 15 Oct 2026.

    Location & entity contextnot_found

    Not established from reviewed free public sources as of 15 Oct 2026.

      Search visibility samplesnapshot

      Public search snapshot, 15 Oct 2026: NAD+ Injections: Are the Wellness Claims Backed by Science?; Special Populations and Clinical Considerations; Semaglutide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes; WeightWell: GLP-1 Weight Loss Guidance by SkinnyRx. Free site-restricted discovery only; search ranking, traffic, volume and authority are not measured.

      THE MODERN DOSING WEEKLY

      The peptide news
      that changes your week.

      Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.